Hem › Lymfom › Pennsylvania › Philadelphia
Kliniska studier för Lymfom i Philadelphia, PA
15 studier för Lymfom söker deltagare vid platser i och runt Philadelphia (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekryterarObservationsstudie
- Children's Hospital of Philadelphia, Philadelphia
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RekryterarFas 1
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
RekryterarFas 2
- University of Pennsylvania, Philadelphia
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekryterarFas 1/2
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
RekryterarFas 1
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
RekryterarFas 1/2
- Research Site, Philadelphia
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
RekryterarFas 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
RekryterarFas 1
- Thomas Jefferson University, Philadelphia
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
RekryterarFas 1
- Hospital of the University of Pennsylvania, Philadelphia
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekryterarFas 1/2
- Thomas Jefferson University, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RekryterarFas 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
RekryterarFas 1
- Children's Hospital of Philadelphia, Philadelphia
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekryterarFas 1
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RekryterarObservationsstudie
- Saint Christopher's Hospital for Children, Philadelphia
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
RekryterarFas 1
- University of Pennsylvania - Abramson Caner Center, Philadelphia
Lymfom-studier i andra städer
- Houston, TX34 studier
- Boston, MA33 studier
- New York City, NY33 studier
- Washington, DC23 studier
- Baldwin Park, CA21 studier
- Chicago, IL20 studier
- Durham, NC17 studier
- St. Louis, MO15 studier
- Cleveland, OH14 studier
- Edison, NJ12 studier
- Atlanta, GA12 studier
- Seattle, WA12 studier
Andra studier i Philadelphia
- Cancer (alla typer)59 studier
- Bröstcancer56 studier
- Icke-småcellig lungcancer51 studier
- Metastaserande cancer46 studier
- Kolorektal cancer44 studier
- Äggstockscancer44 studier
- Prostatacancer44 studier
- Lungcancer36 studier
- Akut myeloid leukemi34 studier
- Hjärtsvikt31 studier
- Endometriecancer28 studier
- Depression26 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.